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CHIMERIC ISOPRENOID SYNTHASES AND
USES THEREOF

synthases, and represent reactions committing carbon from
the general isoprenoid pathWay to end products in the
monoterpene, sesquiterpene, and diterpene classes, respec

STATEMENT AS TO FEDERALLY SPONSORED
RESEARCH

tively.
TWo important biochemical distinctions betWeen the pre
nyltransferase and synthase reactions are illustrated in FIG.

This invention Was made in part With Government

funding, and the Government therefore has certain rights in

2. The prenyltransferases catalyZe carbon-carbon bond for

the invention.

mation betWeen tWo substrate molecules, Whereas the syn
thases catalyZe an intramolecular carbon-carbon bond for

BACKGROUND OF THE INVENTION

10

ensuing polymer. Prenyltransferases differ in the length of

enZymes, their encoding genes, and uses thereof.
The term isoprenoid is used to refer to a family of

compounds derived from the isoprene building block. In

particular, plant isoprenoids comprise a structurally diverse

the allyic substrates that can be accepted in initiating these
reactions. The synthases are also substrate speci?c.
15

group of compounds that can be divided into classes of

products.

that are primary metabolites include sterols, carotenoids,

biochemical functions to speci?c membrane systems,
respectively. Isoprenoids that are classi?ed as secondary
metabolites include monoterpenes, sesquiterpenes, and
diterpenes. These compounds are said to mediated important
interactions betWeen plants and their environment. For

example, speci?c terpenoids have been correlated With
plant-plant (Stevens, In1Isopentoids in Plants, Nes, W. D.
Fuller, G., and Tsai, L.-S., eds., Marcel Dekker, NeW York,
pp. 65—80, 1984), plant-insect (Gibson and Pickett, Nature
3021608, 1983), and plant-pathogen interactions (Stoessl et

20

25

pene synthases are shoWn in FIG. 3. In step 1, the initial
ioniZation of FPP is folloWed by an intramolecular electro
moiety and the distal double bond to form germacene A, a

macrocylic intermediate. Internal ring closure and formation
of the eudesmane carbonium ion constitutes step 2. For
30

tobacco 5-epi-aristolochene synthase (TEAS), the terminal
step is a hydride shift, methyl migration, and deprotonation
at C9 giving rise to 5-epi-aristolochene as depicted in step

3a. Hyoscyamus muticus vetispiradiene synthase (HVS)
shares a common mechanism at steps 1 and 2, but differs
35

pounds is their universal ?ve-carbon building block, iso

from TEAS in the third partial reaction in Which a ring
contraction Would occur due to alternative migration of an

prene. The “biogenic isoprene rule” Was employed to ratio

electron pair. In each case, a monomeric protein of approxi

naliZe the biosynthetic origins of all terpenoids derived from

mately 64 kD catalyZes the complete set of partial reactions
and requires no cofactors other than Mg+2.

isoprene (RuZicka,Experientia 101357, 1953). The polymer
iZation of tWo diphosphorylated isoprene building blocks

The biosynthesis of isoprenoids such as cyclic terpenes is
said to be determined by key branch point enZymes referred
to as terpene synthases. The reactions cataylZed by terpene
synthases are complex, intramolecular cycliZations that may
involve several partial reactions. For example, the bioor
ganic rationale for the cycliZation of FPP by tWo sesquiter

phillic attack betWeen the carbon bearing the diphosphate

al., Phytochemistry 151855, 1976).
The common denominator for this diverse array of com

HoWever, diverse sesquiterpene synthases, for example, can
utiliZe the same substrate to produce different reaction

primary and secondary metabolites (FIG. 1). Isoprenoids
groWth regulators, and the polyprenol substituents of
dolichols, quinones, and proteins. These compounds are
essential for membrane integrity, photoprotection, orches
tration of developmental programs, and anchoring essential

mation. The prenyltransferases also catalyZe reactions With
very little variance in the stereochemistry or length of the

This invention relates to modi?ed isoprenoid synthase

40

(e.g., IPP and dimethylallyl) generates geranyl diphosphate

SUMMARY OF THE INVENTION

(GPP), a linear C10 intermediate that can be converted to

In general, the invention features a chimeric isoprenoid
synthase polypeptide including a ?rst domain from a ?rst
isoprenoid synthase joined to a second domain from a

cyclic or linear end-products representing the monoterpenes,
or used in another round of polymeriZation. The addition of

a third isoprene unit to GPP generates farnesyl diphosphate

45

(FPP), Which can also be converted to cyclic or linear

products representing the sesquiterpene class. Continuing
the polymeriZation and chemical differentiation cycle leads
to the production of other classes of terpenoids named
according to the number of isoprene building blocks leading

production of isoprenoid reaction products that are not
produced in the absence of the second domain of the second,

heterologous isoprenoid synthase. In preferred
50

to their biosynthesis, for example, the addition of a third IPP

embodiments, the chimeric isoprenoid synthase is capable of
catalyZing at least tWo different isoprenoid reaction prod
ucts; the isoprenoid reaction products are cyclic; the second

to FPP generates geranylgeranyl diphosphate (GGPP).
These polymeriZation reactions are catalyZed by prenyl
transferases that direct the attack of a carbocation (an
electron de?cient carbon atom resulting from the loss of the
diphosphate moiety of one substrate) to an electron-rich
carbon atom of the double bond on the IPP molecule (FIG.
2). The electrophilic nature of these reactions is said to be
unusual relative to more general nucleophilic condensation

second, heterologous isoprenoid synthase, Whereby the chi
meric isoprenoid synthase is capable of catalyZing the

domain of the second, heterologous isoprenoid synthase also
55

determines the ratio of the isoprenoid reaction products of
the chimeric isoprenoid synthase; the ?rst domain from the

cycliZation of GPP, FPP, and GGPP are referred to as

?rst isoprenoid synthase is a plant isoprenoid synthase and
the second domain from the second, heterologous isoprenoid
synthase is also from a plant isoprenoid synthase.
Preferably, the chimeric isoprenoid synthase is chosen
from the group consisting of (a) the tobacco-Hyoscyamus
CH4 chimeric isoprenoid synthase; (b) the tobacco
Hyoscyamus CH10 chimeric isoprenoid synthase; (c) the
tobacco-Hyoscyamus CH11 chimeric isoprenoid synthase;
(d) the tobacco-Hyoscyamus CH12 chimeric isoprenoid
synthase; (e) the tobacco-Hyoscyamus CH13 chimeric iso
prenoid synthase; or
the tobacco-Hyoscyamus CH14

monoterpene, sesquiterpene, and diterpene synthases or

chimeric isoprenoid synthase, all as described herein.

reactions, but this appears to be a common reaction among

60

isoprenoid biosynthetic enZymes and especially those
enZymes involved in catalyZing the cycliZation of various

isoprenoid intermediates (GershenZon and Croteau, In1 Lipid
Metabolism in Plants, Moore, T. S., ed., CRC Press, Boca
Raton, Fla., pp. 340—388). The enZymes responsible for the

65
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In preferred embodiments, the chimeric isoprenoid syn
thase catalyzes the production of an isoprenoid reaction
product that is of agricultural, pharmaceutical, commercial,
or industrial signi?cance (e.g., an antifungal agent, antibac

ing amino acid sequence). Such domains may be bonded by
any means, including, Without limitation, a peptide bond or

chemical linkage.
By “domain” is meant a contiguous stretch of amino acids
Within a polypeptide or protein.

terial agent, or antitumor agent).
In other related aspects, the invention features DNA,

By “isoprenoid” is meant a compound that is derived from
an isoprene building block. In particular, isoprenoid com

vectors, and cells (for eXample, E. coli, Sacchromyces
cerevisae, animal or plant cells) encoding or containing a

pounds include, Without limitation, monoterpenes,

chimeric isoprenoid synthase polypeptide.
In another aspect, the invention features a chimeric iso

prenoid synthase polypeptide including an asymmetrically

diterpenes, sesquiterpenes, and sterols. As described herein,
10

isoprenoids are found in a variety of organisms, for eXample,

positioned homologous domain Whereby the chimeric iso
prenoid synthase is capable of catalyZing the production of

animal, fungal, or bacterial sources.

isoprenoid reaction products (preferably, cyclic products)

the chimeric polypeptide at a site Which differs from its

When the domain is positioned at its naturally-occurring site

in the isoprenoid synthase polypeptide.

By “asymmetrically positioned” is meant located Within
15

In another aspect, the invention features a method for

producing a chimeric isoprenoid synthase polypeptide, the
method involving: (a) providing a cell transformed With
DNA encoding a chimeric isoprenoid synthase positioned
for eXpression in the cell; (b) culturing the transformed cell
under conditions for eXpressing the DNA; and (c) recovering
the chimeric isoprenoid synthase.
By “isoprenoid synthase” is meant a polypeptide that is
capable of catalyZing a reaction involving the intramolecular

20

apparent from the folloWing description of the preferred
DETAILED DESCRIPTION
25

FIG. 1 is a schematic illustration shoWing the isoprenoid

biosynthetic pathWay With respect to the type of end prod
ucts and their respective physiological functions. Broken
30

reactions that are catalyZed by prenyltransterases and ter
FIG. 3 is a schematic illustration shoWing a reaction
35

geranyl diphosphate (GPP), farnesyl diphosphate (FPP), and
geranylgeranyl diphosphate (GGPP), respectively. Anumber
40

FIG. 4A is a schematic illustration shoWing the chimeric
constructs used to map catalytic domains Within sesquiter

pene synthases. Line draWings depict composite diagrams
45

constructs Were prepared using a combination of the avail
50

enZymes having a molecular Weight of about 40 to 100 kD.
Genes encoding a number of monoterpene, diterpene, and
sesquiterpene synthases have been described for a number of

By “polypeptide” or “protein” is meant any chain of

?cation (for eXample, glycosylation or phosphorylation).
By “joined to” is meant covalently bonded either directly
or indirectly (i.e., the domains are separated by an interven

able restriction endonuclease sites and ampli?cation of
select regions using PCR and PCR primers harboring con
venient restriction endonuclease sites. Correspondence
betWeen unique restriction endonuclease sites and amino
acid positions are noted.
FIG. 4B is a photograph of a TLC eXperiment shoWing

plant and microbial organisms (see, for eXample, Hohn and

amino acids, regardless of length or post-translational modi

for Wildtype (i.e., TEAS and HVS) and chimeric
(CH1—CH14) sesquiterpene synthase genes that Were engi
neered into the bacterial eXpression vector pGBT-T19. Gene

3081103, 1994; and Gambliel and Croteau, J. Biol. Chem.

1994).

erpene synthases. Partial reactions 1 and 2 are considered
common to both types of synthases. Mechanistic differences
in partial reactions 3a and 3b are suf?cient to account for the

different reaction products shoWn.

Biochem. Biophys. 3091184, 1994; Vogeli et al., Plant
Physiol. 931182, 1990; Guo et al., Arch. Biochem. Biophys.

Beremand, Gene 791131, 1989; Proctor and Hohn, J. Biol.
Chem. 26814543, 1993; Facchini and Chappell, Proc. Natl.
Acad. Sci. 89111088, 1992; Back and Chappell, J. Biol.
Chem. 27017375, 1995; Colby et al., J. Biol. Chem.
268123016, 1993; Mau and West, Proc. Natl. Acad. Sci.
9118497, 1994; Chen et al., Arch. Biochem. Biophys.
3241255, 1994; and Cane et al., Biochemistry 3315846,

mechanism for the synthesis of eremophilane (tobacco

5-epi-aristolochene synthase, TEAS) and vetispiradiene
(Hyoscyamus vetispiradiene synthase, HVS) type sesquit

et al., J. Biol. Chem. 26914012, 1994; Croteau et al., Arch.

2591740, 1984). In general, terpene synthases are soluble

arroWs indicate multiple steps or reactions.
FIG. 2 is a schematic illustration shoWing the various

pene synthases.

aristolochene synthase, vetispiradiene synthase, and

1989; Cane and Pargellis,Arch. Biochem. Biophys. 2541421,
1987; Munck and Croteau,Arch. Biochem. Biophys. 282158,
1990; Alonso et al.,J. Biol. Chem. 26717582, 1992; Savage

The draWings Will ?rst be described.

DraWings

synthase), and sesquiterpene synthases (for eXample, 5-epi

of terpene synthases from plant and microbial sources have
been isolated and characteriZed (see, for eXample, Moestra
and West, Arch. Biochem. Biophys. 2381325, 1985; Hohn
and Van MiddlesWorth, Arch. Biochem. Biophys. 2511756,
1986; Hohn and Plattner,Arch. Biochem. Biophys. 2721137,

(in this case, the same polypeptide).
Other features and advantages of the invention Will be
embodiments thereof, and from the claims.

limitation, monoterpene synthases (for eXample, limonene
synthase), diterpene synthases (for eXample, casbene
cadinene synthase) that are responsible for cycliZation of

By “heterologous” is meant derived from different
sources (in this case, different polypeptides).
By “homologous” is meant derived from the same source

carbon-carbon bond formation of an allylic diphosphate

substrate (for example, a C10, C15, or C2O allylic diphosphate
substrate) to an isoprenoid product (for eXample, a
monoterpene, diterpene, sesquiterpene, or sterol product).
Examples of such isoprenoid synthases include, Without

position in the naturally-occurring polypeptide.
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synthase enZyme activities in sonicated lysates of E. coli
TB1 cells eXpressing the TEAS, HVS, and chimeric syn
thase constructs (CH1—CH14) and measured using 3H-FPP.

Reaction products Were separated by argentation-TLC and
detected by autoradiography. The radioactivity in 0.5 mm
60

segments of each lane of an argentation-TLC plate Was
determined in a scintillation counter, and radioactivity asso
ciated With the Zones for the TEAS and HVS speci?c

products Was set to 100%.
FIG. 5 is a schematic illustration shoWing the correspon
65 dence betWeen eXons and functional domains Within iso

prenoid synthases. The upper diagram represents the orga
niZation of eXons Within the TEAS gene, Which is nearly

5,824,774
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5
identical to that of the HVS and casbene synthase genes. The
loWer diagram shows the alignment of functional domains to
the exonic organization of the TEAS and HVS genes. Exon
numbers are shoWn Within the upper diagram, and all other
numbers refer to amino acid positions, some of Which
correspond to the noted restriction endonuclease sites.
FIG. 6 is a schematic diagram shoWing a domain sWitch

CH3, CH4, CH12, and CH13 Were constructed using

conventional polymerase chain reaction (PCR)
methodologies, With primers designed for the ampli?cation
of particular segments of the HVS gene. To facilitate direc

tional cloning and maintenance of reading frame, primers
Were also designed to contain convenient restriction sites.
CH3 Was constructed as folloWs. An EcoRI/ClaI restric

ing strategy used to generate a quiescent synthase (QH1).

tion fragment of the TEAS gene Was isolated and ligated to

Substituting the inactive HVS domain corresponding to
exon 4 into CH3 results in a synthase having an altered

the ClaI/KpnI fragment of the HVS gene. The HVS ClaI/
10

enZyme activity.

KpnI fragment Was prepared by PCR methodology using

5‘-d(GGGATCGATGACATAGCCACGTATGAGGTT)-3‘

FIG. 7 is a schematic diagram of a domain sWitching

(SEQ ID NO:1) (ClaI restriction site underlined) as the
forWard primer and 5‘-d(AATACGACTCACTATAG)-3‘

strategy used for producing a chimeric quiescent-casbene

synthase, and possible reaction products.

(SEQ ID NO:2) as the reverse primer (corresponding to the

FIG. 8 is a schematic illustration of a domain sWitching 15 T7 sequence found in the multiple cloning site of pBSK)

strategy for producing a chimeric quiescent-cadinene

using pBSK-HVS as the DNA template. The resulting
restriction fragment Was ligated into the EcoRI/KpnI sites of

synthase, and possible reaction products.

the pGBT-T19 vector.

CHIMERIC ISOPRENOID SYNTHASES

CH4 and CH13 Were constructed in a similar manner, but

Plasmids designed for expressing a chimeric synthase
Were generated by substituting a portion of a gene encoding

using the forWard ampli?cation primers 5‘-d(CGA

a domain from tobacco 5-epi-aristolochene synthase With a
portion of a gene encoding a domain from Hyoscyamus

(HincII restriction site underlined) and 5‘-d (TAT

vetispiradiene synthase. These plasmids Were expressed in
bacteria, and bacterial lysates Were prepared and assayed for

GTCAACATGGTTTATTGAGGGATA)-3‘ (SEQ ID N013)
25

sesquiterpene synthase activity. The sesquiterpene synthase
assays included an argentation-thin layer chromatography
(TLC) analysis Which distinguished the aristocholene and
vetispiradiene reaction products (Back and Chappell, J. Biol.

ClaI/KpnI fragment of the TEAS gene into the EcoRI/KpnI

prepared using forWard ampli?ation primer 5‘-d
G

chimeric synthase constructs Were generated and Were
assayed as folloWs.
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C

T

C

ATCGATAACTCTGCATAATGTAGCATT)-3‘ (SEQ ID
NO:6) (ClaI restriction site underlined).
Chimeric synthases CH6, CH8, CH9, CH10, CH11, and
HindIII fragment of the HVS gene With the HindIII/KpnI
fragment of CH3 generated CH6. CH8 Was created by
ligating the EcoRI/NdeI fragment of HVS With the NdeI/
KpnI fragment of CH3. CH9 Was created by ligating the

EcoRI/NdeI fragment of CH5 With the NdeI/KpnI fragment
of HVS. CH10 Was constructed by ligating the EcoRI/
45

HindIII fragment of HVS With the HindIII/KpnI fragment of
CH4. CH11 Was constructed by ligating the EcoRI/NdeI
fragment of HVS With the NdeI/KpnI fragment of CH4. And
CH14 Was generated by substituting the EcoRI/NdeI frag
ment of CH13 With the corresponding DNA fragment of

of the TEAS gene (corresponding to the EcoRI to HindIII

fragment) With the 3‘ terminal portion of HVS gene
(corresponding to the HindIII to KpnI fragment) into the

pBSK-HVS. The nucleotide junctions of the chimeric con
structs Were con?rmed by double-stranded DNA sequencing

bacterial expression vector pGBT-T19 (Gold
Biotechnology) predigested With EcoRI and KpnI.

using the dideoxy nucleotide chain termination kit, accord
ing to the manufacturer’s instructions (U.S. Biochemical

CH2 Was prepared by ligating the 5‘ terminal portion of

Corp).

the TEAS gene (corresponding to the EcoRI to NdeI
55

T19.

Chimeric synthases Were expressed in E. coli TB1 cells.
Procedures for groWth of the bacterial cells, induction of

gene expression, measurement of sesquiterpene synthase

CH5 Was prepared by ligating the 5‘ terminal portion of

enZyme activity, and the determination of total protein in the
bacterial lysates Were performed according to the methods

the HVS gene (corresponding to the EcoRI to HindIII

fragment) With the 3‘ terminal portion of TEAS gene
(corresponding to the HindIII to KpnI fragment) into pGBT
T19.

CH7 Was prepared by ligating the 5‘ terminal portion of
the HVS gene (corresponding to the EcoRI to NdeI

T19.

G

CH14 Were constructed as folloWs. Ligation of the EcoRI/

plasmid.

fragment) With the 3‘ terminal portion of TEAS gene
(corresponding to the NdeI to KpnI fragment) into pGBT

A

(SEQ ID NO:5) (EcoRI restriction site underlined and

270:7375, 1995). The TEAS and HVS cDNA inserts of these
expression plasmids Were oriented With their translation start
codons neighboring the EcoRI restriction site and their 3‘
poly A tail ?anked by the XhoI restriction site of the pSK

fragment) With the 3‘ terminal portion of HVS gene
(corresponding to the NdeI to KpnI fragment) into pGBT

G

translation start codon in bold) and reverse primer 5 ‘-d(GGG

SK (Stratagene), creating the PBSK-TEAS and pBSK-HVS
plasmids, respectively (Back and Chappell, J. Biol. Chem.

Chimeric synthases CH1, CH2, CH5, and CH7 Were
constructed by utiliZing the conserved HindIII and NdeI
restriction sites found betWeen the tobacco and Hyoacyamus
genes. CH1 Was prepared by ligating the 5‘ terminal portion

G

GAATTCCATGGCCTCAGCAGCAGTTGCAAACTNF)-3‘

Full-length cDNAs for the tobacco 5-epi-aristolochene
(HVS) Were cloned into the EcoRI/XhoI sites of pBluescript

CH12 Was prepared by ligating a PCR fragment corre
sponding to the ?rst 1326 nucleotides of CH4 With the
sites of the pGBT-T19 vector. The CH4 fragment Was

Chem. 270:7375, 1995). As shoWn in FIG. 4A, fourteen

synthase (TEAS) and Hyoscyamus vetispiradiene synthase

TCTAGATCTCTATGACGATTATGAA)-3‘ (SEQ ID
NO:4) (XbaI restriction site underlined), respectively.
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described by Back and Chappell (Arch. Biochem. Biophys.
315:527, 1994; J. Biol. Chem. 27017375, 1995). Reaction
products Were separated by developing G60 silica TLC
plates impregnated With 15% silver nitrate in benZene:hex
anezdiethyl ether (50:50:1). For qualitative evaluations, TLC
plates Were sprayed With En3hance surface ?uorography
spray (Dupont) and exposed to Kodak XAR-5 ?lm for 2 to
5 days at —70° C. For quantitative evaluations, 0.5 mm Zones

5,824,774
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of an entire lane from a TLC plates Were scraped into

having HVS- and TEAS-speci?city. CH12 represented a

scintillation vials, and the radioactivity Was determined
using a Packard 1500 Liquid Scintillation Counter. The

substitution of the HincII to ClaI fragment of the tobacco

gene With the corresponding Hyoscyarnus gene fragment,

dominant reaction products generated by the synthase activi
ties resulting from expression of the TEAS, HVS, CH4, and

and resulted in the production of an enzyme having HVS

and TEAS-speci?city. Cornparing CH11 to CH13 provided

CH14 constructs in bacterial lysates Were also veri?ed by

a further re?nernent in the domain characteriZation of the

gas chromatography (GC) and gas chromatography-mass
spectroscopy (GC-MS) according to the conditions
described by Chappell et al. (Phytochemistry 26:225 9, 1987)

tobacco enZyrne responsible for the TEAS-speci?c products.

(data not shoWn). In addition, mass spectra pro?les were

compared to that published for 5-epi-aristolochene (Anke
and Sterner, Planta Med. 57:344, 1991) and the predicted
fragrnentation pattern for vetispiradiene (EnZell et al., Mass
Spectrometry Rev. 3:395, 1984).
As shoWn in FIGS. 4A—B, the dominant reaction product
resulting from the expression of the tobacco TEAS gene
expressed Was 5-epi-aristolochene, and vetispiradiene Was
found to be the dominant reaction product resulting from the
expression of the HVS gene. The predominant reaction
products generated by the expression of CH1 and CH2 Were

The fact that CH13 Was found to be a multifunctional
10

enZyrne indicated that the 81 amino acids encoded by the
DNA fragment residing betWeen the NdeI to XbaI restriction
sites of the tobacco cDNA Were sufficient for formation of

the predominant TEAS speci?c products. This interpretation
Was con?rrned by substituting the domain contained Within
the NdeI/XbaI HVS cDNA restriction fragment of CH14
15

20

With that of the TEAS gene (FIG. 4A).
As shoWn in FIG. 4B, the predominant reaction product(s)
of the Wildtype tobacco TEAS and Hyoscyarnus HVS genes
expressed in bacteria rnigrated on silver nitrate-TLC plates
With Rf values of 0.41 and 0.31, values consistent With
previous characteriZation of these products as 5-epi

also HVS-speci?c (i.e., vetispiradiene), with enzyme spe

aristolochene and vetispiradiene, respectively (Back and

ci?c activities similar to those found for HVS that Was

Chappell, J. Biol. Chem. 270:7375, 1995; Back et al.,Arch.

expressed from the PBSK-HVS plasrnid. These results indi

Biochem. Biophys. 315:527, 1994). GC and GC-MS analy

cated that the amino-terminal half of TEAS and HVS Were

functionally equivalent With respect to the HVS carboxy

25

terrninus and do not contribute to the speci?city of the
reaction product. CH7, having an HVS amino terminus and

bicyclic sesquiterpene (20%) ([M]+ ion at rn/Z of 204). The

a TEAS carboxy terrninus, is the converse construct of CH2,

and the resulting synthase activity Was expected to result in

expression of a TEAS-speci?c product (i.e., 5-epi
aristolochene). Irnrnunodetection assays revealed that syn
thase protein produced upon expression of CH7 Was found
to be of the correct siZe and expected abundance (data not
shoWn); hoWever, no enzyme activity Was detected. The lack
of enzyme activity indicated that interactions betWeen the
carboxy and amino terminal portions of the protein contrib
uted to enzyme activity. This interpretation is further sup

30

aristolochene (18%), a bicyclic sesquiterpene (43%), and
35
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other chirneric synthases, even though the absolute level of
expressed protein was similar to the other constructs (as
45

and CH12 Were generated in a ratio of 60—70% TEAS

speci?c to 30—40% HVS-speci?c. In contrast, an inverse
ratio of reaction products resulted from expression of con
structs CH13 and CH14. This result indicated that the region
encompassed by the XbaI to HincII dornain in?uenced the
50

corresponding to the NdeI and ClaI restriction sites Within
the TEAS and HVS genes. Expression of CH4 unexpectedly
resulted in the production of a chimeric synthase protein

relative ratio of reaction products generated by the multi
functional chirneric synthase enZyrnes. These results indi
cated that tWo separate and distinct dornains Within the

synthase peptide contributed directly to the types of reaction
products generated, and are interrupted by another domain

capable of generating reaction products re?ective of both the
TEAS and HVS enZyrnes. We interpreted this result to
indicate that amino acids 261 to 379 Within the tobacco

Another domain of the synthase proteins Was identi?ed by
comparing the relative ratio of the predominant reaction

products produced by the rnultifunctional chirneric synthase
enZyrnes (FIG. 4A). For example, the reaction products
resulting from expression of constructs CH4, CH10, CH11,

determined by irnrnunodetection, data not shoWn). Substi
erated by CH6.
Comparison of CH2 and CH3 chirneric synthases pro
vided evidence for speci?city of end-product forrnation
residing Within a domain of approximately 181 amino acids,

In addition, studies relying on affinity puri?cation of
histidine-tagged recornbinant synthase proteins has revealed
5 other minor reaction products, each representing approxi
rnately 1% of the total products, With all 5 found at the same
relative abundance in all the reaction assays.
Ratio-Deterrninant Dornain

loWer speci?c activity of synthase enzyme activity than the

tuting an HVS carboxy-terrninal region Was found to restore
the speci?c activity to the synthase enzyme that Was gen

predominant HVS reaction product Was vetispiradiene
(>90%) ([M]+ ion at rn/Z of 204 With a base peak at rn/Z 41
and a series of predictable ions at rn/Z 175, 108, 94, and 68),
and the predominant reaction products of CH4 Were 5-epi

vetispiradiene (32%) (data not shoWn).

ported by comparing the speci?c activity of the enzymes
generated by the expression of the CH5 and CH6 constructs.
CH5 resulted in the expression of a product having a 10-fold

ses indicated that the predominant TEAS reaction products
Were 5-epi-aristolochene (70% of total products, based on
percentage of total peak areas from GC analysis) and a

55

Which We refer to as the ratio-deterrninant dornain (FIG. 5).

Site-Directed Mutagenesis
Additional analysis of the product speci?city and ratio

5-epi-aristolochene synthase are responsible for the TEAS

speci?c products (i.e., the region corresponding to the NdeI

deterrninant dornains was determined using conventional

to HincII fragment of the cDNA), While amino acids 379 to
442 Within the Hyoscyarnus protein are responsible for the

site-directed rnutagenesis methodologies. The results of this
analysis are presented in Table I (beloW). For example, the
DDXXD rnotif, found Within the aristolochene speci?c

60

HVS-speci?c products (i.e., the region corresponding to the
HincII to ClaI fragment of the cDNA).
Our interpretation Was con?rrned by evaluating the
expression products of CH11 and CH12. CH11 represented
the substitution of the NdeI to HincII fragment of the

Hyoscyarnus gene With the corresponding tobacco gene
fragment, and resulted in the production of an enzyme

domain, is a conserved sequence that is found in a variety of

terpene biosynthetic enZyrnes including TEAS and HVS.
This acidic amino acid cluster is said to coordinate a metal
65

cofactor that is necessary to neutraliZe the diphosphate
moiety of FPP in an otherWise lipophilic pocket. Substitu
tion of the ?rst aspartic acid residue (D301) of the DDXXD

5,824,774
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motif With either glutamic acid (overall charge conservation)

Within the primers, is substituted for the corresponding

or valine (net loss of acidic charge) residues (i.e., D301QE

region of CH3. In generating such constructs, care is exer
cised to maintain appropriate amino acid residues and the

and D301QV) resulted in the formation of an inactivated
enZyme. Aconserved substitution of the second aspartic acid

correct reading frame, and expression testing of the con
struct entails a measurement of the protein level in the

(D302) With a glutamic acid residue (i.e., D302—>E) also
inactivated chimeric synthase enZyme activity by 95%, and
resulted in a slight alteration of the product distribution of
the multifunctional enZyme.
TABLE I
Mutation
target

Mutated
amino

gene

acid

10

Aristolochene

out using TLC, and comparing the Rf values of the experi

Speci?c
Activity

Product ratio

Vetispiradiene

mental sample to those generated by the TEAS and HVS
enZymes. Retention times of the reaction products (e.g.,

(nmol/mg h’1

germacrene or germacrene-like reaction product) are also
15

CH4

66%

34%

34

D301V
R287A
D301V
D301E
D302E

No
No
No
No

activity
activity
activity
activity
51%

49%

0
0
0
0
1.8

20

K3471
H360S
H364S

64%
63%
65%

36%
32%
35%

32
29
38

25

Hyoscyarnus speci?c domain (HincII/ClaI region)
CH4
CH4
CH4
CH4

T408A
K420M
H422A
N436S

67%
68%
67%
70%

33%
32%
33%
30%

48
29
30
32

CH4

AT437,

61%

39%

33

ating novel macrocyclic isoprenoids or isoprenoids having
altered stereochemical properties. For example, isoprenoid
synthases such as casbene synthase, a diterpene synthase
Which catalyZes the synthesis of a macrocyclic diterpene
harboring a cyclopropyl side group, and cadiene synthase, a

30

sesquiterpene synthase that catalyZes the synthesis of a

bicyclic sesquiterpene, provide domains useful for engineer
ing enZymes capable of producing macrocylic isoprenoids or
isoprenoid reaction products having altered sterochemical

438VI

The sites for directed substitutions Within the ratio

determinant domain (i.e., K347QI, H360QS, H364QS)

The quiescent synthase is useful for providing suf?cient
amounts of the germacrene reaction intermediate(s) (or
derivatives thereof) to con?rming the chemical rationaliZa
tion for the EAS and VS reactions, and produces a template
chimeric synthase that may be used for the introduction of
novel terminal steps in the overall synthase reaction scheme.
Chimeric Casbene and Cadinene Synthases
Chimeric isoprenoid synthases are also useful for gener

Ratio determinant domain (Xbal/HincII region)
CH4
CH4
CH4

monitored using GC, GC-MS, and NMR according to stan
dard methods.

Substrate binding domain (Ndel/Xbal region)
Tobacco
CH4
CH4
CH4
CH4

soluble and insoluble fractions of bacterial lysates by immu
noblotting techniques, as Well as by enZyme assays.
In addition, large scale enZyme reactions are performed,
the reaction product(s) are extracted into hexane, and the
products are puri?ed by HPLC methods. Additional evalu
ation of the quiescent enZyme reaction products is carried

35

Were inferred by an analysis of reports that hypothesiZed the
importance of charged amino acid residues (e.g., histidine or

properties. A general scheme for producing such chimeric
synthases is presented in FIGS. 7 and 8.
To construct such chimeric casbene and cadienne

synthases, quiescent amino terminal domains (and other

lysine) in synthase enZymology, and these sites represented

synthase domains as necessary) are substituted With those

those amino acids Which displayed the greatest charge

from casbene and cadinene synthase using convenient

differences in comparisons betWeen the TEAS and HVS
primary sequences. None of the three mutations analyZed

40

restriction sites and PCR ampli?cation of selected regions as
described above. Sequences corresponding to the

had any effect on overall catalytic activity or the ratio of

N-terminal, plastid targeting sequence of the casbene syn

products formed.

thase are deleted in these constructs. Chimeric constructs are

Amino acid substitutions Within the HVS speci?c domain
Were chosen on the basis of comparisons betWeen secondary

structural predictions of the HVS and TEAS proteins. Those
amino acids mutated appeared to contribute disproportion
ately to structural distortions in the secondary structure
models of these tWo proteins, largely because of charge
considerations. HoWever, as shoWn in Table I (above),

45

thase activity in bacteria and/or activity generating reaction
products Which migrate With Rfs different from aris
50

substitutions involving charged to non-charged (i.e.,
T408—>A, K420QM, H422—>A) or reduced charged
(N436—>S, A437QT, V438—>I) amino acids did not affect
overall enZyme activity, nor the synthesis rate of one product
or the other.
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Quiescent Synthases

tolochene and vetispiradiene standards are considered useful
in the invention. Reaction products are also analyZed for
their retention times by GC and subjected to GC-MS and
NMR, as necessary. Those domains of casbene synthase and
cadinene synthase Which contribute to the synthesis of
unique reaction products may also be subjected to ?ne detail

mapping using a strategy analogous to that depicted in FIG.

To generate a quiescent synthase, the inactive domain

4A.

corresponding to exon 4 of HVS is substituted With the
corresponding active domain of CH3, as outlined in FIG. 6.
CH3 contains an inactive domain corresponding to exon 6 of

expressed in bacteria, bacterial lysates are examined for
chimeric synthase activity, and reaction products are char
acteriZed as described above, for example, using
argentation-TLC. Constructs supporting high levels of syn

60

Production of Other Chimeric Isoprenoid Synthases
Using the standard molecular techniques described
herein, other chimeric synthases may be readily generated

TEAS, has convenient NdeI and XbaI restriction sites for the
desired substitution, and can be overexpressed in bacteria to

Which include domains from knoWn or neWly isolated

high levels. Domain sWitching is accomplished using stan

for activity using, for example, any appropriate enZyme

synthase enZymes. Such chimeric synthases may be tested
assays knoWn to those in the art, or by standard immuno

dard molecular techniques, as described herein. In one

particular example, a PCR ampli?cation product of HVS
cDNA corresponding to exon 4, encompassing amino acids
261 to 342 and containing appropriate NdeI and XbaI sites

65

detection techniques.
The isolation of additional synthase coding sequences is

also possible using standard cloning strategies and tech
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niques that are Well known in the art. For example, using all

may be used to provide the recombinant protein. The precise

or a portion of the amino acid sequence of a knoWn synthase

host cell used is not critical to the invention. The chimeric

polypeptide, one may readily design synthase-speci?c oli

gonucleotide probes, including synthase degenerate oligo

synthase protein may be produced in a prokaryotic host, for
example, E. coli TB1, or in a eukaryotic host, for example,

nucleotide probes (i.e., a mixture of all possible coding
sequences for a given amino acid sequence). These oligo

Saccharomyces cerevisiae, mammalian cells (for example,

nucleotides may be based upon the sequence of either DNA

including, Without limitation, algae, tree species, ornamental
species, temperate fruit species, tropical fruit species, veg
etable species, legume species, monocots, dicots, or in any

strand and any appropriate portion of synthase nucleotide
sequence. General methods for designing and preparing
such probes are provided, for example, in Ausubel et al.,
1996, Current Protocols in Molecular Biology, Wiley
Interscience, NeW York, and Berger and Kimmel, Guide to
Molecular Cloning Techniques, 1987, Academic Press, NeW

COS 1 or NIH 3T3 cells), or any of a number of plant cells

10

to, Conifers, Petunia, Tomato, Potato, Tobacco, Arabidopsis,
Lettuce, Sun?oWer, Oilseed rape, Flax, Cotton, Sugarbeet,

York. These oligonucleotides are useful for synthase gene
isolation, either through their use as probes capable of
hybridiZing to a synthase complementary sequences or as 15

primers for various ampli?cation techniques, for example,
polymerase chain reaction (PCR) cloning strategies.
Hybridization techniques and screening procedures are

Celery, Soybean, Alfalfa, Medicago, Lotus, Vigna,
Cucumber, Carrot, Eggplant, Cauli?oWer, Horseradish,
Morning Glory, Poplar, Walnut, Apple, Asparagus, Rice,
MaiZe, Millet, Onion, Barley, Orchard grass, Oat, Rye, and
Wheat.
Such cells are available from a Wide range of sources

Well knoWn to those skilled in the art and are described, for

example, in Ausubel et al. (supra); Berger and Kimmel
(supra); Chen at al.Arch. Biochem. Biophys. 3241255, 1995;
and Sambrook et al., Molecular Cloning: A Laboratory
Manual, Cold Spring Harbor Laboratory Press, NeW York. If
desired, a combination of different oligonucleotide probes

20

may be used for the screening of a recombinant DNA library.

25

including: the American Type Culture Collection (Rockland,
Md.); or from any of a number seed companies, for example,

W. Atlee Burpee Seed Co. (Warminster, Pa.), Park Seed Co.

(Greenwood, SC), Johnny Seed Co. (Albion, Me.), or
Northrup King Seeds (Harstville, S.C.). Descriptions and

The oligonucleotides may be detectably-labeled using meth

sources of useful host cells are also found in Vasil I.K., Cell

Culture and Somatic Cell Genetics of Plants, Vol I, II, III
Laboratory Procedures and Their Applications Academic
Press, NeW York, 1984; Dixon, R. A., Plant Cell Culture-A
Practical Approach, IRL Press, Oxford University, 1985;

ods knoWn in the art and used to probe ?lter replicas from
a recombinant DNA library. Recombinant DNA libraries are

prepared according to methods Well knoWn in the art, for
example, as described in Ausubel et al. (supra), or they may

plant of commercial or agricultural signi?cance. Particular
examples of suitable plant hosts include, but are not limited

30

be obtained from commercial sources.

Green et al., Plant Tissue and Cell Culture, Academic Press,
NeW York, 1987; and Gasser and Fraley, Science 24411293,

As discussed above, synthase oligonucleotides may also
be used as primers in ampli?cation cloning strategies, for

(1989).

example, using PCR. PCR methods are Well knoWn in the art

synthase polypeptide is carried on a vector operably linked

and are described, for example, in PCR Technology, Erlich,
ed., Stockton Press, London, 1989; PCR Protocols.'A Guide
to Methods and Applications, Innis et al., eds., Academic
Press, Inc., NeW York, 1990; and Ausubel et al. (supra).
Primers are optionally designed to alloW cloning of the
ampli?ed product into a suitable vector, for example, by

For prokaryotic expression, DNA encoding a chimeric

35

to control signals capable of effecting expression in the
prokaryotic host. If desired, the coding sequence may
contain, at its 5‘ end, a sequence encoding any of the knoWn

40

including appropriate restriction sites at the 5‘ and 3‘ ends of

signal sequences capable of effecting secretion of the
expressed protein into the periplasmic space of the host cell,
thereby facilitating recovery of the protein and subsequent
puri?cation. Prokaryotes most frequently used are various

the ampli?ed fragment (as described herein). If desired, a

strains of E. coli; hoWever, other microbial strains may also

synthase gene may be isolated using the PCR “RACE”
technique, or Rapid Ampli?cation of cDNA Ends (see, e.g.,

be used. Plasmid vectors are used Which contain replication

Innis et al. (supra)). By this method, oligonucleotide primers

45

origins, selectable markers, and control sequences derived
from a species compatible With the microbial host.

based on a synthase sequence are oriented in the 3‘ and 5‘

Examples of such vectors are found in PouWels et al. (supra)

directions and are used to generate overlapping PCR frag
ments. These overlapping 3‘-and 5‘-end RACE products are
combined to produce an intact full-length cDNA. This
method is described in Innis et al. (supra); and Frohman et

or Ausubel et al. (supra). Commonly used prokaryotic
control sequences (also referred to as “regulatory elements”)
are de?ned herein to include promoters for transcription
50

al., Proc. Natl. Acad. Sci. USA 8518998, (1988).
Useful synthase sequences may be isolated from any
appropriate organism. Con?rmation of a sequence’s relat
edness to the synthase polypeptide family may be accom
plished by a variety of conventional methods, for example,
sequence comparison. In addition, the activity of any syn
thase protein may be evaluated according to any of the
techniques described herein.

initiation, optionally With an operator, along With ribosome
binding site sequences. Promoters commonly used to direct
protein expression include the beta-lactamase

(penicillinase), the lactose (lac) thr tryptophan (Trp)
(Goeddel et al., Nucl. Acids Res. 814057 (1980)), and the tac
55

promoter systems, as Well as the lambda-derived PL pro

transformation of a suitable host cell With all or part of a

moter and N-gene ribosome binding site (Simatake et al.,
Nature 2921128 (1981)).
One particular bacterial expression system for chimeric
synthase polypeptide production is the E. coli pET expres
sion system (Novagen). According to this expression
system, DNA encoding a chimeric synthase polypeptide is

chimeric synthase DNA (for example, the chimeric synthase

inserted into a pET vector in an orientation designed to alloW

cDNAs described above) in a suitable expression vehicle or

expression. Since the chimeric synthase gene is under the
control of the T7 regulatory signals, expression of chimeric
synthase is induced by inducing the expression of T7 RNA
polymerase in the host cell. This is typically achieved using

Chimeric Isoprenoid Synthase Polypeptide Expression
Chimeric synthase polypeptides may be produced by

With a plasmid construct engineered for increasing the
expression of a chimeric synthase polypeptide in vivo.
Those skilled in the ?eld of molecular biology Will
appreciate that any of a Wide variety of expression systems

60
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host strains Which express T7 RNA polymerase in response
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to IPTG induction. Once produced, recombinant chimeric

can be accomplished in most cell types. Recombinant pro

synthase polypeptide is then isolated according to standard

tein expression can be increased by DHFR-mediated ampli
?cation of the transfected gene. Methods for selecting cell
lines bearing gene ampli?cations are described in Ausubel et

methods knoWn in the art, for example, those described
herein.
Another bacterial expression system for chimeric syn

al. (supra); such methods generally involve extended culture
in medium containing gradually increasing levels of meth
otrexate. DHFR-containing expression vectors commonly

thase polypeptide production is the pGEX expression system
(Pharmacia). This system employs a GST gene fusion sys
tem that is designed for high-level expression of a gene or
gene fragment as a fusion protein With rapid puri?cation and
recovery of the functional gene product. The chimeric

used for this purpose include pCVSEII-DHrF and

pAdD26SV(A) (described in Ausubel et al., supra). Any of
10

synthase protein of interest is fused to the carboxyl terminus
of the glutathione S-transferase protein from Schistosoma

de?cient CHO cell line (for example, CHO DHFR'cells,
ATCC Accession No. CRL 9096) are among the host cells
preferred for DHFR selection of a stably-transfected cell line
or DHFR-mediated gene ampli?cation.

japonicum and is readily puri?ed from bacterial lysates by
af?nity chromatography using Glutathione Sepharose 4B.
Fusion proteins can be recovered under mild conditions by

15

elution With glutathione. Cleavage of the glutathione
S-transferase domain from the fusion protein is facilitated by
the presence of recognition sites for site-speci?c proteases
upstream of this domain. For example, proteins expressed in
pGEX-2T plasmids may be cleaved With thrombin; those
expressed in pGEX-3X may be cleaved With factor Xa.
For eukaryotic expression, the method of transformation

the host cells described above or, preferably, a DHFR

A chimeric synthase polypeptide is preferably produced
by a stably-transfected plant cell or by a transgenic plant. A
number of vectors suitable for stable transfection of plant
cells or for the establishment of transgenic plants are avail
able to the public; such vectors are described in PouWels et

20

al. (supra), Weissbach and Weissbach (supra), and Gelvin et
al. (supra). Methods for constructing such cell lines are
described in, e.g., Weissbach and Weissbach (supra), and

or transfection and the choice of vehicle for expression of

Gelvin et al. (supra). Typically, plant expression vectors

the chimeric synthase polypeptide Will depend on the host
system selected. Transformation and transfection methods of
numerous organisms, for example, the baker’s yeast Sac
charomyces cerevisiae, are described, e.g., in Ausubel et al.

include (1) a cloned chimeric synthase gene under the
transcriptional control of 5‘ and 3‘ regulatory sequences and
(2) a dominant selectable marker. Such plant expression
vectors may also contain, if desired, a promoter regulatory
region (for example, one conferring inducible or constitutive
expression, or environmentally- or developmentally

(supra); Weissbach and Weissbach, Methods for Plant
Molecular Biology, Academic Press, 1989; Gelvin et al.,
Plant Molecular Biology Manual, KluWer Academic
Publishers, 1990; Kindle, K., Proc. Natl. Acad. Sci. USA
87:1228 (1990); Potrykus, 1., Annu. Rev. Plant Physiol.

25
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transcription termination site, and/or a polyadenylation sig

Plant Mol. Biology 42:205 (1991); and BioRad (Hercules,
Calif.) Technical Bulletin #1687 (Biolistic Particle Delivery
Systems). Expression vehicles may be chosen from those

35

provided, e.g., in Cloning Vectors:A Laboratory Manual (P.
H. PouWels et al., 1985, Supp. 1987); Gasser and Fraley

(supra); Clontech Molecular Biology Catalog (Catalog
1992/93 Tools for the Molecular Biologist, Palo Alto,
Calif.); and the references cited above.
One preferred eukaryotic expression system is the mouse

regulated, or pathogen-or Wound-inducible, or cell- or

tissue-speci?c expression), a transcription initiation start
site, a ribosome binding site, an RNA processing signal, a
nal.
The chimeric synthase DNA sequence of the invention
may, if desired, be combined With other DNA sequences in
a variety of Ways. The chimeric synthase DNA sequence of
the invention may be employed With all or part of the gene

sequences normally associated With a synthase protein. In its
40

component parts, a DNA sequence encoding a chimeric
synthase protein is combined in a DNA construct having a

3T3 ?broblast host cell transfected With a pMAMneo

transcription initiation control region capable of promoting

expression vector (Clontech). pMAMneo provides: an RSV

transcription and translation in a host cell.

LTR enhancer linked to a dexamethasone-inducible MMTV

LTR promoter, an SV40 origin of replication Which alloWs
replication in mammalian systems, a selectable neomycin
gene, and SV40 splicing and polyadenylation sites. DNA
encoding a chimeric synthase polypeptide is inserted into the
pMAMneo vector in an orientation designed to alloW

45

expression. The recombinant chimeric synthase polypeptide

50

functional fragment thereof Will be joined at its 5‘ end to a

is then isolated as described beloW. Other preferable host

cells Which may be used in conjunction With the pMAMneo
expression vehicle include COS cells and CHO cells (ATCC
Accession Nos. CRL 1650 and CCL 61, respectively).

Alternatively, if desired, a chimeric synthase polypeptide
is produced by a stably-transfected mammalian cell line. A

transcription initiation regulatory region such as the
sequence naturally found in the 5‘ upstream region of a
synthase structural gene. Numerous other transcription ini
tiation regions are available Which provide for constitutive
or inducible regulation.

55

For applications When developmental, cell, tissue,
hormonal, environmental, or pathogen-inducible expression
are desired, appropriate 5‘ upstream non-coding regions are
obtained from other genes; for example, from genes regu

number of vectors suitable for stable transfection of mam
malian cells are available to the public, e.g., see PouWels et

al. (supra); methods for constructing such cell lines are also
publicly available, e.g., in Ausubel et al. (supra). In one

In general, the constructs Will involve regulatory regions
functional in plants Which provide for production of a
chimeric synthase protein as discussed herein. The open
reading frame coding for the chimeric synthase protein or

lated during seed development, embryo development, leaf
development, or in response to a pathogen.
60

example, cDNA encoding the chimeric synthase polypeptide

Regulatory transcript termination regions may also be
provided in DNA constructs of this invention as Well.

is cloned into an expression vector Which includes the

Transcript termination regions may be provided by the DNA

dihydrofolate reductase (DHFR) gene. Integration of the
plasmid and, therefore, the chimeric synthase-encoding gene

sequence encoding a synthase protein or any convenient
transcription termination region derived from a different
gene source. The transcript termination region Will contain
preferably at least 1—3 kb of sequence 3‘ to the structural
gene from Which the termination region is derived. Such

into the host cell chromosome is selected for by inclusion of
0.01—300 uM methotrexate in the cell culture medium (as
described in Ausubel et al., supra). This dominant selection

65
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genetically-engineered plants are useful for a variety of
industrial and agricultural applications as discussed below.
Importantly, this invention is applicable to gymnosperms
and angiosperms, and Will be readily applicable to any neW
or improved transformation or regeneration method.
An example of a useful plant promoter according to the

In addition to the aforementioned 5‘ regulatory control
sequences, the expression vectors may also include regula
tory control regions Which are generally present in the 3‘

regions of plant genes (Thornburg et al., Proc. Natl. Acad.
Sci. USA. 84:744 (1987); An et al., Plant Cell 1:115

(1989)). For example, the 3‘ terminator region may be

invention is a caulimovirus promoter, for example, a cauli

?oWer mosaic virus (CaMV) promoter. These promoters
confer high levels of expression in most plant tissues, and
the activity of these promoters is not dependent on virally
encoded proteins. CaMV is a source for both the 35S and

19S promoters. In most tissues of transgenic plants, the
CaMV 35S promoter is a strong promoter (see, e.g., Odell et
al., Nature 313:810 (1985)). The CaMV promoter is also
highly active in monocots (see, e.g., Dekeyser et al., Plant
Cell 2:591 (1990); Terada and Shimamoto,Mol. Gen. Genet.
220:389, (1990)). Moreover, activity of this promoter can be

10

15

be used as selectable markers in photosynthetic-de?cient

strains. Alternatively, the green-?uorescent protein from the
20

Current Biology 6:325 (1996)). Finally, genes encoding
herbicide resistance may be used as selectable markers;
useful herbicide resistance genes include the bar gene
25

Basta® (Hoechst A. G., Frankfurt, Germany).

promoters, each With its oWn distinct characteristics embod
30

ug/ml (kanamycin), 20—50 ug/ml (hygromycin), or 5—10

Gen. Genet. 219:365 (1989); and Takahashi et al. Plant J.
35

rbcS-3A described by Kuhlemeier et al. (Plant Cell 1:471

(1989); the maiZe rbcS promoter described by Schaffner and
Sheen, (Plant Cell 3:997 (1991); or the chlorophyll a/b
binding protein gene found in pea described by Simpson et
al. (EMBO J. 4:2723 (1985)), hormone-regulated gene

ug/ml (bleomycin). Auseful strategy for selection of trans
formants for herbicide resistance is described, e.g., by Vasil
et al., supra.
It should be readily apparent to one skilled in the art of

40

expression (for example, the abscisic acid (ABA) responsive
sequences from the Em gene of Wheat described by Marcotte
et al. (Plant Cell 1:969 (1989); the ABA-inducible HVA1

and HVA22, and the rd29A promoters described for barley
and Arabia'opsis by Straub et al. (Plant Cell 6:617 (1994),
Shen et al. (Plant Cell 7:295 (1994)), and Wound-induced

Ef?cient use of selectable markers is facilitated by a
determination of the susceptibility of a plant cell to a
particular selectable agent and a determination of the con

centration of this agent Which effectively kills most, if not
all, of the transformed cells. Some useful concentrations of
antibiotics for tobacco transformation include, e.g., 75—100

tal cues. These include gene promoters that are responsible

for heat-regulated gene expression (see, e.g., Callis et al.,
Plant Physiol. 882965 (1988); Takahashi and Komeda, Mol.

2:751 (1992)), light-regulated gene expression (e.g., the pea

encoding the enZyme phosphinothricin acetyltransferase and
conferring resistance to the broad spectrum herbicide

at an appropriate level, or at an appropriate developmental

response to the environment, hormones, and/or developmen

jelly?sh Aequorea victoria may be used as a selectable

marker (Sheen et al., Plant J. 8:777, 1995; Chiu et al.,

time. For this purpose, there are an assortment of gene

ied in its regulatory sequences, shoWn to be regulated in

plant systems include genes encoding antibiotic resistance
genes, for example, those encoding resistance to

hygromycin, kanamycin, bleomycin, G418, streptomycin, or
spectinomycin. Genes required for photosynthesis may also

Other useful plant promoters include, Without limitation,
the nopaline synthase promoter (An et al., Plant Physiol.
88:547 (1988)) and the octopine synthase promoter (Fromm
et al., Plant Cell 1:977 (1989)).
For certain applications, it may be desirable to produce
the chimeric synthase gene product in an appropriate tissue,

nopaline synthase signals.
The plant expression vector also typically contains a
dominant selectable marker gene used to identify those cells
that have become transformed. Useful selectable genes for

further increased (i.e., betWeen 2—10 fold) by duplication of
the CaMV 35S promoter (see e.g., Kay et al., Science
236:1299 (1987); OW et al., Proc. Natl. Acad. Sci. USA.
84:4870 (1987); and Fang et al., Plant Cell 1:141 (1989)).

included in the expression vector to increase stability of the
mRNA. One such terminator region may be derived from the
PI-II terminator region of potato. In addition, other com
monly used terminators are derived from the octopine or

molecular biology, especially in the ?eld of plant molecular
biology, that the level of gene expression is dependent, not
only on the combination of promoters, RNA processing
signals, and terminator elements, but also on hoW these
elements are used to increase the levels of selectable marker

gene expression.
45

Plant Transformation

Upon construction of the plant expression vector, several

gene expression (for example, of WunI described by SiebertZ

standard methods are available for introduction of the vector

et al. (Plant Cell 1:961 (1989)), or organ-speci?c gene

into a plant host, thereby generating a transgenic plant.
These methods include (1) Agrobacterium-mediated trans
formation (A. tumefaciens or A. rhizogenes) (see, e.g., Lich

expression (for example, of the tuber-speci?c storage pro
tein gene described by Roshal et al. (EMBO J. 6:1155
(1987); the 23-kDa Zein gene from maiZe described by
Schernthaner et al. (EMBO J. 7:1249 (1988); or the French
bean [3-phaseolin gene described by Bustos et al. (Plant Cell

50

tenstein and Fuller In: Genetic Engineering, vol 6, P. W. J.

Rigby, ed, London, Academic Press, 1987; and Lichtenstein,
C. P., and Draper, J,. In: DNA Cloning, Vol II, D. M. Glover,

1:839 (1989)); and pathogen-inducible gene expression
described by Chappell et al. in US. Ser. Nos. 08/471,983,

ed, Oxford, IRI Press, 1985)), (2) the particle delivery
55

system (see, e.g., Gordon-Kamm et al., Plant Cell 2:603

08/443,639, and 08/577,483, hereby incorporated by refer

(1990); or BioRad Technical Bulletin 1687, supra), (3)

ence.

microinjection protocols (see, e.g., Green et al., supra), (4)
polyethylene glycol (PEG) procedures (see, e.g., Draper et

Plant expression vectors may also optionally include

RNA processing signals, for example, introns, Which have
been shoWn to be important for efficient RNA synthesis and
accumulation (Callis et al., Genes and Dev. 1:1183 (1987)).
The location of the RNA splice sequences can dramatically
in?uence the level of transgene expression in plants. In vieW
of this fact, an intron may be positioned upstream or
doWnstream of a chimeric synthase polypeptide-encoding

al., Plant Cell Physiol. 23:451 (1982); or e.g., Zhang and
60

Wu, Theor. Appl. Genet. 76:835 (1988)), (5) liposome
mediated DNA uptake (see, e.g., Freeman et al., Plant Cell

Physiol. 25 :1353 (1984)), (6) electroporation protocols (see,
e.g., Gelvin et al., supra; Dekeyser et al., supra; Fromm et

sequence in the transgene to modulate levels of gene expres

al., Nature 319:791 (1986); Sheen, Plant Cell 2:1027
(1990); or Jang and Sheen Plant Cell 6:1665 (1994)), and (7)
the vortexing method (see, e.g., Kindle supra). The method

sion.

of transformation is not critical to the present invention. Any
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method Which provides for ef?cient transformation may be

plant tissue culture media containing kanamycin (e.g., 100

employed. As neWer methods are available to transform

pig/ml). Kanamycin-resistant shoots are then placed on plant

crops or other host cells, they may be directly applied.
The following is an example outlining one particular
technique, an Agrobacterium-mediated plant transforma

tissue culture media Without hormones for root initiation.

tion. By this technique, the general process for manipulating

plants can then be soWed in soilless medium and groWn in
a greenhouse. Kanamycin-resistant progeny are selected by
soWing surfaced steriliZed seeds on hormone-free

genes to be transferred into the genome of plant cells is
carried out in tWo phases. First, cloning and DNA modi?
cation steps are carried out in E. coli, and the plasmid
containing the gene construct of interest is transferred by

conjugation or electroporation into Agrobacterium. Second,
the resulting Agrobacterium strain is used to transform plant
cells. Thus, for the generaliZed plant expression vector, the
plasmid contains an origin of replication that alloWs it to
replicate in Agrobacterium and a high copy number origin of
replication functional in E. coli. This permits facile produc
tion and testing of transgenes in E. coli prior to transfer to

Kanamycin-resistant plants are then selected for greenhouse
groWth. If desired, seeds from self-fertiliZed transgenic

10

for example, Ausubel et al. supra; Gelvin et al. supra).
Transgenic plants expressing the selectable marker are
then screened for transmission of the transgene DNA by
standard immunoblot and DNA detection techniques. Each
15

Resistance genes can be carried on the vector, one for

tissue and developmental patterns of transgene expression.

selection in bacteria, for example, streptomycin, and another
that Will function in plants, for example, a gene encoding
kanamycin resistance or herbicide resistance. Also present

Consequently, a number of transgenic lines are usually
screened for each transgene to identify and select plants With

the most appropriate expression pro?les.

on the vector are restriction endonuclease sites for the
addition of one or more transgenes and directional T-DNA
25

Transgenic lines are generally evaluated for levels of
transgene expression. Expression at the RNA level is deter

mined initially to identify and quantitate expression-positive
plants. Standard techniques for RNA analysis are employed
and include PCR ampli?cation assays using oligonucleotide

Will be transferred to the plant.

In another example, plant cells may be transformed by
shooting into the cell tungsten microprojectiles on Which
cloned DNA is precipitated. In the Biolistic Apparatus

primers designed to amplify only transgene RNA templates
and solution hybridiZation assays using transgene-speci?c
probes (see, e.g., Ausubel et al., supra). The RNA-positive
plants are then analyZed for protein expression by Western
immunoblot analysis using speci?c antibodies to the chi
meric synthase (see, e.g., Ausubel et al., supra). In addition,

(Bio-Rad) used for the shooting, a gunpoWder charge (22
caliber PoWer Piston Tool Charge) or an air-driven blast

drives a plastic macroprojectile through a gun barrel, An
aliquot of a suspension of tungsten particles on Which DNA
has been precipitated is placed on the front of the plastic
macroprojectile. The latter is ?red at an acrylic stopping

positive transgenic plant and its transgenic progeny are
unique in comparison to other transgenic plants established
With the same transgene. Integration of the transgene DNA
into the plant genomic DNA is in most cases random, and the
site of integration can profoundly effect the levels and the

Agrobacterium for subsequent introduction into plants.

border sequences Which, When recogniZed by the transfer
functions of Agrobacterium, delimit the DNA region that

kanamycin-containing media. Analysis for the integration of
the transgene is accomplished by standard techniques (see,

35

plate that has a hole through it that is too small for the

macroprojectile to pass through. As a result, the plastic

macroprojectile smashes against the stopping plate, and the
tungsten microprojectiles continue toWard their target

in situ hybridiZation and immunocytochemistry according to
standard protocols can be done using transgene-speci?c
nucleotide probes and antibodies, respectively, to localiZe
sites of expression Within transgenic tissue.
Once the recombinant chimeric synthase protein is
expressed in any cell or in a transgenic plant (for example,
as described above), it may be isolated, e.g., using affinity

through the hole in the plate. For the present invention, the
target can be any plant cell, tissue, seed, or embryo. The

chromatography. In one example, an anti-chimeric synthase

DNA introduced into the cell on the microprojectiles
becomes integrated into either the nucleus or the chloroplast.

supra, or by any standard technique) may be attached to a

In general, transfer and expression of transgenes in plant

antibody (e.g., produced as described in Ausubel et al.,
45

cells are noW routine practices to those skilled in the art, and

column and used to isolate the polypeptide. Lysis and
fractionation of chimeric synthase-producing cells prior to

have become major tools to carry out gene expression

af?nity chromatography may be performed by standard

studies in plants and to produce improved plant varieties of

methods (see, e.g., Ausubel et al., supra). Once isolated, the
recombinant protein can, if desired, be further puri?ed, for

agricultural or commercial interest.

example, by high performance liquid chromatography (see,

Transgenic Plant Regeneration

e.g., Fisher, Laboratory Techniques In Biochemistry And
Molecular Biology, eds., Work and Burdon, Elsevier, 1980).
These general techniques of polypeptide expression and

Plants cells transformed With plant expression vectors can

be regenerated, for example, from single cells, callus tissue,
or leaf discs according to standard plant tissue culture
techniques. It is Well knoWn in the art that various cells,
tissues, and organs from almost any plant can be success

puri?cation can also be used to produce and isolate useful
55

fully cultured to regenerate an entire plant; such techniques

chimeric synthase fragments or analogs.
Use
The invention described herein is useful for a variety of

are described, e.g., in Vasil supra; Green et al., supra;
Weissbach and Weissbach, supra; and Gelvin et al., supra.
In one particular example, a cloned chimeric synthase

agricultural, pharmaceutical, industrial, and commercial
purposes. For example, the methods, DNA constructs,

polypeptide under the control of the EAS4 promoter and the
nopaline synthase terminator and carrying a selectable

proteins, and transgenic organisms, including the bacteria,

marker (for example, kanamycin resistance) is transformed

isoprenoid synthesis, manufacturing, and production.

into Agrobacterium. Transformation of leaf discs (for
example, of tobacco leaf discs), With vector-containing

to modulate isoprenoid synthase activity by providing chi

Agrobacterium is carried out as described by Horsch et al.

(Science 227:1229 (1985)). Putative transformants are
selected after a feW Weeks (for example, 3 to 5 Weeks) on

yeast, and plants described herein, are useful for improving
Our results presented above demonstrate that it is possible
65

meric synthases. In this manner, various synthase reaction
products may be modi?ed, controlled, or manipulated,
resulting in enhancement of production of numerous syn

